An international research team has demonstrated that treating HIV-AIDS with interleukin-2 is ineffective. As a result, the researchers recommend that clinical trials on this compound be stopped.
An international research team has demonstrated that treating HIV-AIDS with interleukin-2 is ineffective. As a result, the researchers recommend that clinical trials on this compound be stopped.